Drug Discovery · Boston, MA · Founded 2024 · Privately Held (backing)
Operator of a biotechnology company intended to create bispecific antibodies for treating immunological and inflammatory disorders. Bambusa Therapeutics is based in Boston, MA and was founded in 2024. It was valued at $555 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $143 million across 4 recorded rounds; the latest was a $40 million Series A2 in Oct 2025.
PMV mark · valuation
$555.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$143.0M
Last round
Early Stage VC (Series A2)
Oct 2025
Cap table — not yet on record
Bambusa Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bambusa Therapeutics with a free account
·The complete investor list: 11 names
·Watch Bambusa Therapeutics: the Monday email on marks, rounds and moves
Where does Bambusa Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Bambusa Therapeutics's 4 recorded funding rounds.
